The heads of centres collaborating with the WHO in biological research on mental disorders decided to develop a series of consensus statements on key issues in biological research and treatment of psychiatric problems. The statement on prophylactic use of anticholinergics in patients on neuroleptic treatment is the second of the proposed series.
No takes yet. Share an insight, caveat, or question.
A 1990 study studied this question.